Spanish Red Biotech Pipeline

Amgen

tezepelumab

Type: Biodrugs/ Drugs
Therapeutic area: Autoimmune & Inflammation
Dermatology
Indication: Efficacy and safety of tezepelumab in the chronic spontaneous urticaria treatment
Phase: 2Phase II in Spain, 1Phase I